PHA 543613 hydrochloride
Tocris Bioscience | Catalog # 3092
Key Product Details
Description
Product Description
PHA 543613 hydrochloride is a potent α7 nAChR agonist that displays selectivity over α3β4, α1β1γδ, α4β2 and 5-HT3 receptors. Positively influences sensory gating and memory in in vivo models of schizophrenia. Orally active and brain penetrant.Licensing Information
Sold for research purposes under agreement from Pfizer Inc.
Product Specifications for PHA 543613 hydrochloride
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 30.78 | 100 | |
| DMSO | 7.69 | 25 |
Preparing Stock Solutions for PHA 543613 hydrochloride
The following data is based on the product molecular weight 307.78.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 3.25 mL | 16.25 mL | 32.49 mL |
| 5 mM | 0.65 mL | 3.25 mL | 6.50 mL |
| 10 mM | 0.32 mL | 1.62 mL | 3.25 mL |
| 50 mM | 0.06 mL | 0.32 mL | 0.65 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 21 publications citing the usage of this product.
- Faghih Allosteric modulators of the α7 nicotinic acetylcholine receptor. J.Med.Chem. 2008 PMID: 18198823
- Acker Discovery of N-[3R,5R)-1-azabicyclo[3.2.1]ocy-3-yl]furo-[2,3-c]pyridine-5-carboxamide as an agonist of the α7 nicotinic acetylcholine receptor: in vitro and in vivo activity. Bioorg.Med.Chem.Letts. 2008 PMID: 1849016
- Wishka Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the α7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia; synthesis and st J.Med.Chem. 2006 PMID: 16821801
Product Documents for PHA 543613 hydrochloride
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for PHA 543613 hydrochloride
For research use only
Related Research Areas
Citations for PHA 543613 hydrochloride
Customer Reviews for PHA 543613 hydrochloride (1)
Have you used PHA 543613 hydrochloride?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
-
Species: RatAssay Type: In VivoVerified Customer | Posted 02/14/2018Sometimes we experienced poor solubility in physiological saline. Slight warming and ultrasonics might help.We used PHA 543613 in behavioral pharmacology experiments and tested its cognitive enhancer effect. PHA 543613 was found effective in different behavioral paradigms, and in different models of cognitive impairment. For instance, PHA 543613 dose-dependently reversed scopolamine induced transient amnesia in the spontaneous alternation (t-maze) task of rats.
There are no reviews that match your criteria.